COLL - Collegium Pharmaceutical announces $25M accelerated share repurchase deal
2023-11-09 08:42:26 ET
More on Collegium Pharmaceutical
- Collegium Pharmaceutical: Delivering On Promises
- Collegium Pharmaceutical: Pipeline Continues As Share Buyback Initiates
- Collegium pain med Nucynta gets US market exclusivity extension
For further details see:
Collegium Pharmaceutical announces $25M accelerated share repurchase deal